Journal: Scientific reports
This retrospective cohort study evaluated the impact of percutaneous endoscopic gastrostomy (PEG) on patients with head and neck cancer (HNC) at a Thai hospital between 2007 and 2022.
After propensity score matching, 1,361 patients with PEG were compared to 1,361 without.
Results demonstrated that PEG placement was associated with:
- Significantly longer median survival (approximately 2.1 years vs. 1.1 years)
- Reduced loss of body weight
- Reduced loss of serum albumin
Multivariable analysis confirmed PEG as a significant factor for improved 3-month survival (adjusted hazard ratio 0.24).
The study suggests PEG placement supports better nutritional status and survival outcomes in HNC patients.